Israel's Largest Pharma and Hospital Team Up for Patients

When Israel's biggest pharmaceutical company teams up with one of its most innovative hospitals, patients around the world win.

Teva Pharmaceuticals and Sheba Medical Center's ARC Innovation signed a groundbreaking partnership last month. Their goal is simple but powerful: help Israeli health tech startups scale faster and get life-changing innovations to patients who need them.

The timing couldn't be better. Both organizations just won grants from the Israel Innovation Authority to create pilot sites for testing new medical technologies. Now they're combining their strengths to give startups something rare: access to both a global pharmaceutical giant and a world-class hospital system at once.

"This should significantly accelerate the adoption of new technologies," says Igal Gurevich, who leads strategic partnerships at Teva Israel. "And ultimately everything comes back to the patient."

Here's how it works. Startups with promising technologies can now test their innovations at Teva facilities worldwide and at Sheba Medical Center. A company developing better medication tracking through AI, for example, could pilot it in Teva's supply chain and in Sheba's patient care units simultaneously.

The partnership focuses on three key areas. First, giving startups dual access to pharmaceutical manufacturing and hospital settings. Second, combining research capabilities so Teva's drug development teams can work alongside Sheba's physicians and laboratories. Third, solving shared operational challenges like keeping medications at the right temperature from factory to patient bedside.

ARC has already launched over 100 healthcare startups and operates in 10 countries. Teva appointed 60 innovation leaders worldwide to identify problems that new technologies could solve. Together, they're creating a fast track from idea to implementation.

Angela Rabinovich, ARC's chief business officer, sees the bigger picture. "This is about bringing together two organizations with a global innovation mindset and a shared drive to change healthcare," she told The Media Line.

A joint steering committee now meets quarterly to evaluate projects. Working groups advance the most promising initiatives. When challenges overlap, like improving medication adherence or speeding up drug development, both organizations can tackle them together.

The Ripple Effect

This partnership creates a multiplier effect that reaches far beyond Israel's borders. Startups get global validation faster. Teva improves how it develops and delivers medications. Sheba enhances patient care with cutting-edge tools. But the real winners are patients everywhere who'll benefit from innovations that might have taken years longer to reach them.

The model proves that collaboration beats competition when the goal is healing.